Working... Menu

A Study to Evaluate Ketamine for the Treatment of Rett Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03633058
Recruitment Status : Recruiting
First Posted : August 16, 2018
Last Update Posted : May 17, 2019
Vanderbilt University Medical Center
Information provided by (Responsible Party):
Rett Syndrome Research Trust

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2019
  Estimated Study Completion Date : December 2019